Novartis AG vs Ross Stores, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Ross Stores, Inc. trades at $235 (market cap $75.63B). The key difference: Novartis AG is far larger — about 3.8× Ross Stores, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | ROST | |
|---|---|---|
Market Cap | $290.25B | $75.63B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $240.13 |
52-Week Low | $113.50 | $134.02 |
Enterprise Value | $330.27B | $76.23B |
Dividend Yield | 3.17% | 0.75% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →